NMI (NMIH)
(Delayed Data from NSDQ)
$41.52 USD
+0.34 (0.83%)
Updated Oct 16, 2024 04:00 PM ET
After-Market: $41.53 +0.01 (0.02%) 7:58 PM ET
2-Buy of 5 2
B Value D Growth B Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$41.52 USD
+0.34 (0.83%)
Updated Oct 16, 2024 04:00 PM ET
After-Market: $41.53 +0.01 (0.02%) 7:58 PM ET
2-Buy of 5 2
B Value D Growth B Momentum B VGM
Zacks News
Will NMI Holdings (NMIH) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
NMI Holdings (NMIH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Mercury General (MCY) in Focus: Stock Moves 8.5% Higher
by Zacks Equity Research
Mercury General (MCY) saw a big move last session, as its shares jumped more than 8% on the day, amid huge volumes.
What's in the Cards for MetLife (MET) Stock in Q2 Earnings?
by Zacks Equity Research
MetLife's (MET) Q2 earnings should gain from a strong property and casualty business, partly offset by higher expenses.
What's in Store for Lincoln National (LNC) in Q2 Earnings?
by Zacks Equity Research
Lincoln National (LNC) Q2 earnings are likely to gain from higher sale in life, annuities and Group Protection businesses.
Allstate (ALL) Q2 Earnings to Suffer From Catastrophe Loss
by Zacks Equity Research
Allstate (ALL) Q2 earnings should suffer from cat loss partly offset by premium growth.
Is a Beat in Store for Qorvo (QRVO) This Earnings Season?
by Zacks Equity Research
Qorvo (QRVO) to benefit from increased demand in the performance-tier for RF Flex and RF Fusion based solutions as well as antenna tuning, discrete components and BAW-based multiplexers.
Is a Beat in the Cards for XL Group (XL) in Q2 Earnings?
by Zacks Equity Research
Better investment results and premium growth are likely to aid XL Group's (XL) Q2 earnings. However, escalating expenses and a probable cat loss might dampen chances of a surprise.
What's in Store for CNA Financial (CNA) in Q2 Earnings?
by Zacks Equity Research
Improved premiums and better investment results might boost CNA Financial (CNA) in Q2. However, rising expenses and a probable catastrophe loss might be spoilers.
Here's Why You Must Add CNA Financial (CNA) to Portfolio
by Zacks Equity Research
CNA Financial (CNA) strives to up its game for reaping more returns to investors on the back of six factors.
Allstate (ALL) Catastrophe Woes Continue With Losses in May
by Zacks Equity Research
Allstate (ALL) expects to suffer loss from catastrophe events in May.
Here's Why You Should Add Alleghany (Y) to Your Portfolio
by Zacks Equity Research
Alleghany (Y) continues to raise optimism for investors with top-line growth, strategic buyouts and a robust capital position.
Here's Why You Should Hold on to Hartford Financial Stock
by Zacks Equity Research
Hartford Financial (HIG) looks poised for growth, given its rising top line, strategic moves and a declining debt burden.
7 Reasons Why You Should Add Markel (MKL) to Your Portfolio
by Zacks Equity Research
We focus on seven factors, which make Markel (MKL) an attractive pick for investors.
5 Reasons Why Allstate (ALL) Stock is an Attractive Pick Now
by Zacks Equity Research
Allstate (ALL) looks good on the back of its strategic growth initiatives, rising rates and tax cut.
Donegal Group Inks Deal to Sell Donegal Financial Services
by Zacks Equity Research
Donegal Group (DGICA) inks a deal to sell Donegal Financial Services to focus on its core P&C insurance business.
AXIS Capital or Hanover Insurance: Which Stock Scores Better?
by Zacks Equity Research
On comparative assessment, we try and find out which stock, AXIS Capital (AXS) or Hanover Insurance (THG), is a more profitable pick pertaining to fundamentals.
First American & Arm Upgraded by Moody's, Outlook Stable
by Zacks Equity Research
Given a solid earnings performance and effective navigation of the highly cyclical title insurance market, Moody's upgrades senior debt ratings of First American Financial (FAF) and its unit.
American Financial's Premium Growth Solid, Cat Loss a Woe
by Zacks Equity Research
American Financial (AFG) continues to buoy hope among investors with premium growth, favorable combined ratio and a robust capital position. However, cat loss exposure remains a drag.
NMI Holdings (NMIH) Stock Jumps 58% in a Year: Here's Why
by Zacks Equity Research
Bottom-line growth, higher revenues and a solid financial position lead to a surge in NMI Holdings' (NMIH) share price in a year.
CNA Financial Gains From Premium Growth, Cat Loss a Drag
by Zacks Equity Research
CNA Financial (CNA) continues to build trust among investors with premium rise, solid product and service portfolio and strong liquidity. However, exposure to cat loss is a bane.
Markel or XL Group: Which Insurer to Bet on Post Q1 Results?
by Zacks Equity Research
On a comparative assessment, we try and find out which stock, Markel (MKL) or XL Group (XL) is a more attractive pick pertaining to fundamentals.
Will NMI Holdings (NMIH) Continue to Surge Higher?
by Zacks Equity Research
As of late, it has definitely been a great time to be an investor in NMI Holdings, Inc. (NMIH)
Greenlight Capital Unveils Innovation Unit, Boosts Services
by Zacks Equity Research
Greenlight Capital's (GLRE) new innovation unit, Greenlight Re, is expected to amp up its efficiency and quality of products and services available to its clients.
Why Allstate (ALL) Stock Should Be a Part of Your Portfolio
by Zacks Equity Research
Allstate (ALL) looks an attractive bet on the back of its numerous positive factors.
Why You Must Add Travelers Companies (TRV) to Your Portfolio
by Zacks Equity Research
Travelers Companies (TRV) remains poised for growth given a number of positives.